BETHANY BONES: Open Payments
NPI 1811408867 · GLEN MILLS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,735 in 88 payments from 18 companies in 2025. Trend: 2023 $1,796 · 2024 $2,079 · 2025 $1,735
Food & beverage: $1,574Education: $161
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $255 |
| ABBVIE INC. | 22 | $247 |
| Lilly USA, LLC | 6 | $229 |
| Janssen Biotech, Inc. | 9 | $220 |
| PFIZER INC. | 5 | $116 |
| Regeneron Healthcare Solutions, Inc. | 5 | $109 |
| Incyte Corporation | 3 | $81 |
| UCB, Inc. | 3 | $80 |
| E.R. Squibb & Sons, L.L.C. | 3 | $73 |
| Almirall LLC | 3 | $67 |
Products named: TREMFYA, ILUMYA, RINVOQ, EBGLYSS, DUPIXENT, CIBINQO, SKYRIZI, TALTZ.
Industry payments across PA — which companies pay providers there.
